Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Volcano was a U.S. cardiovascular medical device company focused on catheter-based imaging and measurement tools used in interventional cardiology and peripheral vascular procedures. Its core product portfolio included intravascular ultrasound (IVUS) systems, imaging catheters, and functional measurement guidewires used to assess coronary and peripheral vessels during minimally invasive procedures. The company was publicly traded as Volcano Corporation before being acquired by Royal Philips in February 2015. Following the acquisition, the business was integrated into Philips' image-guided therapy operations and the legal entity has since operated under Philips Image Guided Therapy Corporation. The business is healthcare-related, commercial-stage, and centered on devices rather than therapeutics in the drug-development sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Volcano Therapeutics.